08048036315
Mounjaro 7.5 mg Injection affordable injection to USA - Los Angeles | Phoenix Exim |Trusted Exporter

1. General Information

Mounjaro 7.5 mg Prefilled Pen contains tirzepatide, a prescription medicine belonging to the dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist class.

Mounjaro is primarily indicated, in the U.S. prescribing information, as an adjunct to diet and exercise to improve blood-glucose control in adults with type 2 diabetes mellitus. Tirzepatide can influence blood glucose, appetite and body weight.

Mounjaro should be used only under the supervision of a qualified healthcare professional and according to the approved indication in the destination country.

2. Product Information

  • Brand: Mounjaro
  • Active Ingredient: Tirzepatide
  • Strength: 7.5 mg/0.5 mL
  • Dosage Form: Injection
  • Presentation: Single-dose prefilled pen
  • Route: Subcutaneous injection
  • Frequency: Once weekly
  • Drug Class: GIP and GLP-1 receptor agonist
  • Manufacturer/Marketer: Eli Lilly and Company
  • Storage: Refrigerate at 2°C–8°C and protect from light. The single-dose pen may be kept at room temperature up to 30°C for a total of 21 days when required; it must not be frozen.

Mounjaro is available in several strengths, including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg per 0.5 mL.

3. Uses of Mounjaro 7.5 mg

Mounjaro is used as part of an overall treatment plan including diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Tirzepatide may:

  • Help improve blood-glucose control
  • Increase glucose-dependent insulin secretion
  • Reduce glucagon secretion
  • Reduce food intake
  • Contribute to reductions in body weight

The exact approved uses of tirzepatide products can differ between countries, so the product should be supplied and used according to the regulations and approved labeling of the destination market.

4. Benefits of Mounjaro 7.5 mg

Potential therapeutic benefits include:

  • Convenient once-weekly administration
  • Dual GIP and GLP-1 receptor activity
  • Improved blood-glucose control when used as prescribed
  • Helps regulate appetite and food intake
  • Can contribute to weight reduction in patients receiving tirzepatide
  • Prefilled pen presentation can simplify administration

Individual results vary, and Mounjaro is not intended to replace a healthy diet, exercise or professional medical care.

5. Side Effects of Mounjaro 7.5 mg

Like other prescription medicines, Mounjaro may cause side effects. Gastrointestinal reactions are among the most frequently reported.

Potential adverse effects include:

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion/dyspepsia
  • Abdominal pain

Important but less common risks include pancreatitis, serious allergic reactions, severe gastrointestinal reactions, gallbladder problems and kidney injury associated with dehydration.

Seek prompt medical attention for symptoms such as severe or persistent abdominal pain, signs of a serious allergic reaction, significant dehydration or other concerning symptoms.

6. Common Side Effects

The commonly reported side effects of Mounjaro include:

  1. Nausea
  2. Diarrhea
  3. Decreased appetite
  4. Vomiting
  5. Constipation
  6. Indigestion
  7. Abdominal pain

Side effects may be more noticeable when treatment is initiated or the dosage is increased. Speak with a healthcare professional if symptoms are severe, persistent or concerning.

7. How to Use Mounjaro 7.5 mg

Mounjaro is administered once weekly by subcutaneous injection. The injection can generally be given in the abdomen, thigh or upper arm according to the product instructions and healthcare professional's guidance. Injection sites should be rotated.

The usual U.S. dosing schedule starts at 2.5 mg once weekly, followed by 5 mg after at least four weeks. If additional glycemic control is required, the dose may be increased in 2.5 mg increments after at least four weeks on the current dose. Therefore, 7.5 mg should be used only when prescribed as the appropriate dose by a healthcare professional.

Do not change the dose or injection schedule without medical advice.

8. How Mounjaro Works

Tirzepatide activates both GIP and GLP-1 receptors.

Its actions include:

  • Enhancing glucose-dependent insulin secretion
  • Reducing glucagon levels
  • Lowering fasting and after-meal blood glucose
  • Reducing food intake
  • Supporting reductions in body weight

Because its insulin-related effects are glucose-dependent, tirzepatide acts differently from medicines that directly supply insulin.

9. Safety Advice

Before using Mounjaro, patients should inform their healthcare professional about their medical history and all medicines they take.

Important safety points:

  • Do not use Mounjaro if you or your family have a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use it if you have had a serious allergic reaction to tirzepatide or its ingredients.
  • Tell your healthcare professional if you have a history of pancreatitis, severe gastrointestinal problems or diabetic retinopathy.
  • Monitor for symptoms of gallbladder disease.
  • Insulin or insulin-secretagogue therapy may increase the risk of hypoglycemia when used with Mounjaro.
  • Mounjaro can delay gastric emptying and may affect the absorption of some oral medicines.
  • Tell healthcare professionals that you use Mounjaro before surgery or deep sedation because delayed gastric emptying may increase the risk of pulmonary aspiration.
  • Pregnancy requires medical consultation because tirzepatide may pose a risk to the fetus.
  • Keep the pen refrigerated as directed and do not freeze it.
  • Keep the medicine away from children.
  • Use only under a healthcare professional's prescription and supervision.

10. Frequently Asked Questions

Q1. What is Mounjaro 7.5 mg?
Mounjaro 7.5 mg is a tirzepatide injection supplied in a prefilled pen for subcutaneous administration.

Q2. How often is Mounjaro 7.5 mg injected?
Mounjaro is generally administered once weekly. The prescribed dose should be determined by a healthcare professional.

Q3. What is the active ingredient?
The active ingredient is tirzepatide.

Q4. Is Mounjaro available as a prefilled pen?
Yes. Mounjaro is available as a single-dose prefilled pen in multiple strengths, including 7.5 mg/0.5 mL.

Q5. How should Mounjaro be stored?
Single-dose pens should generally be stored refrigerated at 2°C–8°C and protected from light. They should not be frozen.

Q6. Can Mounjaro be used without a prescription?
Mounjaro is a prescription medicine and should be used only under appropriate medical supervision.

Q7. What are the common side effects?
Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain are among the commonly reported adverse reactions.

Q8. Can the dose be changed from 5 mg to 7.5 mg?
Dose escalation should be determined by a healthcare professional. U.S. prescribing information recommends increasing doses in 2.5 mg increments after at least four weeks on the current dose when additional glycemic control is needed.

Q9. Is Mounjaro the same as tirzepatide?
Mounjaro is a brand of medicine whose active ingredient is tirzepatide.

Q10. Does Phoenix Exim export Mounjaro?
Phoenix Exim is a pharmaceutical exporter based in Nagpur, India. Availability, export documentation and shipment of prescription medicines depend on applicable Indian and destination-country regulations.

11. Substitute / Alternative to Mounjaro 7.5 mg

A substitute should not be selected solely on the basis of the same therapeutic purpose or dosage. The appropriate alternative depends on the patient's diagnosis, treatment goals, medical history, current medicines and local approvals.

Depending on the indication and country, healthcare professionals may consider other GLP-1 receptor agonist or incretin-based therapies, such as medicines containing:

  • Semaglutide
  • Dulaglutide
  • Liraglutide
  • Other locally approved tirzepatide products

These are not automatically equivalent substitutes for Mounjaro 7.5 mg, and switching should be done only under professional medical guidance.

12. SEO Keywords

  • Mounjaro 7.5 mg Prefilled Pen
  • Mounjaro 7.5 mg Injection
  • Tirzepatide 7.5 mg Injection
  • Tirzepatide Prefilled Pen
  • Mounjaro 7.5 mg Pharmaceutical Product
  • Mounjaro Tirzepatide Injection
  • Tirzepatide Injection Supplier India
  • Mounjaro Pharmaceutical Exporter India
  • Tirzepatide Medicine Exporter India
  • Mounjaro Exporter from Nagpur
  • Pharmaceutical Exporter Nagpur India
  • Mounjaro 7.5 mg International Supply
  • Tirzepatide 7.5 mg Export India
  • Mounjaro 7.5 mg Global Pharmaceutical Supply
  • Prescription Medicine Exporter India
  • Tirzepatide Injection Supplier
  • Mounjaro Prefilled Injection Pen
  • Mounjaro 7.5 mg B2B Pharmaceutical Supply
  • Tirzepatide Pharmaceutical Supplier
  • Mounjaro 7.5 mg Wholesale Enquiry
  • Tirzepatide 7.5 mg Wholesale Supplier
  • Mounjaro 7.5 mg Exporter USA
  • Mounjaro 7.5 mg Exporter UK
  • Mounjaro 7.5 mg Exporter Australia
  • Mounjaro 7.5 mg Exporter Canada
  • Mounjaro 7.5 mg Exporter Singapore
  • Mounjaro 7.5 mg Exporter South Korea
  • Mounjaro 7.5 mg Exporter UAE
  • Tirzepatide Supplier from India
  • Phoenix Exim Pharmaceutical Exporter
  • Phoenix Exim Nagpur India
  • Trusted Pharmaceutical Exporter India
  • Tirzepatide Injection International Supplier
  • Mounjaro 7.5 mg Pharmaceutical Distribution
  • Tirzepatide 7.5 mg Medicine Supplier
Aug 11th, 2026 2:49 PM

Keywords